Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/6/26 17:48 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 6 | S.dm | -5,905 | 24.53 | 0 | -241 | 1,180 | D | |||||||||||||||
4/6/26 17:44 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Simon Amy | MA | O | Chief Me | 3 | S.m | -736 | 19.12 | 0 | -39 | 103 | D | |||||||||||||||
4/6/26 17:39 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 7 | S | -702 | 30.07 | 0 | -23 | 51 | D | |||||||||||||||
4/6/26 17:39 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 8 | S.d | -1,356 | 30.47 | 0 | -44 | 117 | D | |||||||||||||||
4/6/26 17:34 | 4/1/26 | BEAM | Health | BioPrd | Biological Products, (No Diag | Ciaramella Giuseppe | MA | O | P | 3 | S.d | -1,547 | 28.51 | 0 | -54 | 218 | D | |||||||||||||||
1/5/26 16:16 | 12/31/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Emany Sravan Kumar | MA | O | CFO | 1 | S | -171 | 27.10 | 0 | -6 | 74 | D | |||||||||||||||
10/29/25 13:13 | 10/27/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Fmr LLC | MA | TH | See Rema | 2 | S | -1,004 | 20.56 | 0 | -49 | 3,214 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |